ANALYSIS OF THE GENE PROMOTERS OF MOUSE OSTEOCLAST DIFFERENTIATION FCTOR (RANKL)
ANALYSIS OF THE GENE PROMOTERS OF MOUSE OSTEOCLAST DIFFERENTIATION FCTOR (RANKL)
批准号:
12670204
负责人:
KITAZAWA Riko
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Receptor activator of NF-kB ligand (RANKL) is a membrane-bound signal transducer necessary for the induction of osteoclasts. We characterized the promoter region of the mouse RANKL gene, identifying inverted TATA- and CAAT-boxes, putative Runx2 binding sites (-190, -205 and -365), and a putative vitamin D response element (VDRE, -935). Northern blot and nuclear run-on analyses showed that vitamin D_3 upregulates RANKL gene expression at the transcriptional level, and transient transfectikon studies revealed that the inductive effect of vitamin D_3 was abolished by mutation of the putative VDRE (-937/-922) and deletion of the region up to -723. An elecrophoretic motility shift assay demonstrated that the VDR-RXR_heterodimer binds to AGGTCAGCCTGGTTCA (-937/-922) ; VDRE/nuclear protein supershift complexes bound to anti-VDR and RXRβ_antibodies were detected in vitamin D_3-treated ST2 cells. Furthermore, when cocultured with mouse bone marrow macrophages, later-passage ST2 cells showed a decrease in osteoclastogenesis because of decreased RANKL mRNA expression. However, earlier- and later-passage ST2 cells transfected with a RANKL promoter construct showed the same level of luciferase activity and vitamin D_3 induction, suggesting that a cis-regulatory mechanism might be involved in the dependence of RANKL gene expression on passage number. Since CpG loci (-66/+246) were predominantly methylated in later-passage ST2 cells, CpG methylation around the transcription and translation start sites probably regulates, in part, RANKL gene expression.We have presented our data at various international as well as domestic meeting, and published scientific papers for academic journals.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kitazawa S et al: "Identification of methylated cytosine from archival formalin-fixed paraffin-embedded specimens."Lab Invest. 80. 275-276 (2000)
Kitazawa S 等人:“从档案福尔马林固定石蜡包埋标本中鉴定甲基化胞嘧啶。”Lab Invest。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitazawa R et al.: "Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissues of normal and pathological conditions"Histol Histopathol. 17・1. 179-184 (2002)
Kitazawa R 等人:“正常和病理条件下甲状旁腺激素相关蛋白(PTHrP)的表达”Histol Histopathol 17・1(2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kitazawa R et al.: "Gene expression during fracture healing in normal mouse : in situ hybridization on hard tissues for investigation of regenerative mechanism"Acta Histochem Cytochem. 34・5. 321-328 (2001)
Kitazawa R等:“正常小鼠骨折愈合过程中的基因表达:用于研究再生机制的原位杂交”Acta Histochem Cytochem 34・5(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mon H et al.: "RANK ligand, RANK and OPG expression in type II collagen-induced arthritis mouse"Histochem Cell Biol. (印刷中). (2002)
Mon H 等人:“II 型胶原诱导的关节炎小鼠中的 RANK 配体、RANK 和 OPG 表达”Histochem Cell Biol(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mori H et al.: "RANK ligand, RANK and OPG expression in type II collagen-induced arthritis mouse"Histochem Cell Biol. (印刷中). (2002)
Mori H 等人:“II 型胶原关节炎诱导的小鼠中的 RANK 配体、RANK 和 OPG 表达”Histochem Cell Biol(出版中)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 41 条
Regulatory Mechanism of RANK Gene Expression during Osteoclastic Differentiation of Bone Marrow Macrophage/Monocyte Lineage
-
批准号:21590419
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:KITAZAWA Riko
-
依托单位:
Analysis of transcriptional regulation of RANK gene and osteoclastic differentiation in bone marrow microenvironment
-
批准号:18590372
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.42万
-
财政年份:2006
-
负责人:KITAZAWA Riko
-
依托单位:
ROLE OF RANKL IN OSTEOLYTIC BONE METASTASIS
-
批准号:16590313
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2004
-
负责人:KITAZAWA Riko
-
依托单位:
REGULATORY MECHANISM OF RANKL GENE EXPRESSION
-
批准号:14570188
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2002
-
负责人:KITAZAWA Riko
-
依托单位:
ANALYSIS OF THE HUMAN α6 INTEGRIN PROMOTER
-
批准号:10670206
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:KITAZAWA Riko
-
依托单位:
A STUDY OF GENES DIFFERENTIALLY EXPRESSED BY OSTEOCLASTOGENIC MOUSE STROMAL CELLS
-
批准号:09557021
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.63万
-
财政年份:1997
-
负责人:KITAZAWA Riko
-
依托单位:
A STUDY OF THE REGULATORY MECHANISM OF CYTOKINES ON OSTEOCLASTIC BONE RESORPTION IN POSTMENOPAUSAL OSTEOPOROSIS
-
批准号:08670250
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:KITAZAWA Riko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于RANKL/RANK/OPG通路观察补肾活血方干预半月板白-白区撕裂后软骨下骨的研究
-
批准号:2026JJ81068
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:章俊
-
依托单位:
基于“阴消阳长”理论从RANKL/RANK通路探讨阳和汤调控骨转移乳腺癌免疫微环境增敏免疫的机制研究
-
批准号:2026JJ50610
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:毛丹
-
依托单位:
单核巨噬细胞通过RANK/RANKL/OPG 信号通路调控小鼠P3趾尖骨关节再生的机制研究
-
批准号:JCZRYB202500176
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
RANKL-NFATc1-E-NPP4通路促进破骨细胞嘌呤代谢加速绝经后骨质疏松骨量流失的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:禹宝庆
-
依托单位:
基于网络药理学技术及OPG/RANKL/RNAK信号通路探讨壮骨方防治假体无菌性松动机制研究
-
批准号:JCZRLH202501024
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
OPG-RANKL-RANK轴调控NLRP3炎症小体介导DA神经元变性的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈祥
-
依托单位:
CD8+T细胞通过RANKL-RANK轴和小胶质细胞相互作用重塑脊髓损伤免疫微环境影响干细胞疗效的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:梁仟
-
依托单位:
靶向骨转移68Ga/177Lu-RANKL抑制剂诊疗一体化放射性药物研究
-
批准号:
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2024
-
负责人:陈跃
-
依托单位:
三七素调控RANKL信号的干细胞联合创新疗法治疗骨质疏松的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:仓定伟
-
依托单位:
基于OPG/RANK/RANKL信号通路研究异补骨脂素调控炎症抗骨质疏松的作用机制
-
批准号:2024Y9519
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:陈长贤
-
依托单位: